Subscribe
istock-512332386_bakhtiar_zein
bakhtiarzein / iStockphoto.com
26 June 2017Americas

FDA targets barriers to generic competition

The Food and Drug Administration (FDA) has announced its intention to target the barriers to generic drug competition.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FDA issues new guidance to boost generic competition
3 October 2017   The US Food and Drug Administration has issued new guidance as part of its bid to target the barriers to generic drug competition.
Americas
FDA identifies companies ‘potentially blocking access’ to drug samples
21 May 2018   The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.
Americas
USFDA to modernise generic review with $37.6m funding
19 June 2018   The US Food and Drug Administration is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
FDA issues new guidance to boost generic competition
3 October 2017   The US Food and Drug Administration has issued new guidance as part of its bid to target the barriers to generic drug competition.
Americas
FDA identifies companies ‘potentially blocking access’ to drug samples
21 May 2018   The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.
Americas
USFDA to modernise generic review with $37.6m funding
19 June 2018   The US Food and Drug Administration is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics.

More on this story

Americas
FDA issues new guidance to boost generic competition
3 October 2017   The US Food and Drug Administration has issued new guidance as part of its bid to target the barriers to generic drug competition.
Americas
FDA identifies companies ‘potentially blocking access’ to drug samples
21 May 2018   The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.
Americas
USFDA to modernise generic review with $37.6m funding
19 June 2018   The US Food and Drug Administration is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?